Early trials of the drug VIR-5500 showed it shrinking tumours in some patients ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...

The average age of men who get diagnosed is 67.

In recent decades, there have been enormous developments in cancer treatment. In the past, most patients received chemotherapy, a broad treatment that also damages healthy cells, but for several years ...

A drug for advanced prostate cancer has shown “remarkable” results in an early-stage trial, with patients who had previously stopped being receptive to treatment finding their tumours shrinking, ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...

Prostate cancer overtook breast cancer as the most commonly diagnosed cancer in England earlier this year. NHS data examined by Prostate Cancer UK revealed that 50,751 men were diagnosed with prostate ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...